The hepatitis B X-interacting protein (HBXIP) was originally identified by its interaction with the C-terminus of the HBX, which has been found to enhance the growth of hepatoma cells and promote tumorigenesis [6]. Here, LAMTOR5 is linked to hepatocellular carcinoma.